Home > PJ (current issue) > Leading article | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7447 p414
14 April 2007

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Leading Article

Time to pull together

Repercussions of the Government's decision to remove professional regulation from the Royal Pharmaceutical Society and establish a General Pharmaceutical Council to take responsibility for it may reach far into the by-ways of the profession — and the consequences may ripple through the profession for decades.

“Professional leadership in pharmacy” — the report produced by the King’s Fund off the back of a seminar commissioned by Lord Carter’s working party (p417) — reveals that at the moment there is great enthusiasm among the pharmacy groups and seminar attendees for the establishment of a royal college for pharmacy, or for the pharmacy profession (as the King’s Fund report describes it). Moreover, it is accepted that the impetus for this will come from the Society and the Pharmaceutical Society of Northern Ireland, working in tandem with these other groups — and confirmed by a statement issued by the Society last week.

So far, so good. But a critical question will have to be addressed before too long: who is to be in and who is to be out? Some observant readers of The Journal may realise that we were underplaying this a few weeks ago (17 March, p296) but the landscape seems to be changing so rapidly at the moment that it has become a question that needs to be answered before it can be decided how the royal college will be governed.

The description used by the King’s Fund is telling: “for the pharmacy profession” could encompass pharmaceutical scientists and pharmacy technicians in some capacity. Indeed the Association of Pharmacy Technicians UK has already made it known that technician membership of the proposed royal college is one of its key objectives (PJ, 7 April, p387). Encompassing everyone would probably make economic sense: the more professional groups see that the royal college might offer them status and services, the more sustainable it looks. On the other hand, pharmacists might want to keep the royal college for themselves and believe that their academic interests and support for their professional development will be better served if they adopt a title like the medical royal colleges and become “the royal college of pharmacists”. These issues have already begun to be aired in our letters columns (PJ, 7 April, p396).

Another concern is whether the college will be dominated by community pharmacists (like the Society), or whether it will be taken over by specialists.This may not be acceptable to generalist pharmacists.

Meanwhile, contractors in England may find they gain a stronger voice if anything comes from the mooted discussions between the Pharmaceutical Services Negotiating Committee and the National Pharmacy Association (p415) and, as a result, may consider progression towards a royal college as something of a sideshow.

If ever there were a time for pharmacists to put their differences aside and pull together to develop a strong leadership body, this is it.

Back to Top


©The Pharmaceutical Journal